GENE ONLINE|News &
Opinion
Blog

Daniel Ojeda

WRITTEN BY Daniel Ojeda

Locanabio Raises $100M to Advance CRISPR-Mediated RNA-Targeting Therapies
2020-12-18
Boehringer Ingelheim’s Newest Acquisition Reinforces its Focus on Immuno-Oncology
2020-12-14
Orladeyo’s FDA approval Heralds New Funding for BioCryst
2020-12-13
Novartis’ Chronic Myeloid Leukemia Drug Demonstrates Superior Results to Pfizer’s
2020-12-10
Ionis Initiates Phase 3 Trials for Familial Chylomicronemia Syndrome Treatment
2020-12-06
AstraZeneca Sells its Cholesterol Drug to German Pharma
2020-12-03
Vertex Bags EU Approval for Cystic Fibrosis Treatment in Children Aged 6-11 Years
2020-11-29
FDA Requests Additional Info for Liquidia’s Pulmonary Arterial Hypertension Treatment
2020-11-27
Merck Spends $425 Million to Acquire OncoImmune’s COVID-19 Therapy
2020-11-24
Eli Lilly Forays into Gene Editing with Precision BioSciences Collaboration
2020-11-21
Brainstorm’s Stem Cell Therapy Flunks Phase 3 ALS Trial
2020-11-20
Gilead and Novo Nordisk Present Proof-of-Concept Data for the First Possible NASH Treatment
2020-11-17
Spotlight: New CRISPR-Based Diagnosis for SARS-CoV-2 Detection
2020-11-15
Pfizer’s JAK1 Inhibitor Impresses in Phase 3 Atopic Dermatitis Trial
2020-11-12
Amgen, AstraZeneca’s Tezepelumab Impresses in Phase 3 Asthma Trial
2020-11-11
1 6 7 8 9
Scroll to Top